Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
Go back to Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure| Gilead Sciences (NASDAQ: GILD) | Delayed: 130.34 +0.06 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.28 | 52 Week High | $108.63 | |||
| Open | $131.83 | 52 Week Low | $71.39 | |||
| Day High | $132.86 | P/E | 72.01 | |||
| Day Low | $130.23 | EPS | $1.81 | |||
| Volume | 4,757,560 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 127.47 +1.21 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.26 | 52 Week High | $65.46 | |||
| Open | $127.32 | 52 Week Low | $47.97 | |||
| Day High | $128.83 | P/E | 86.71 | |||
| Day Low | $126.62 | EPS | $1.47 | |||
| Volume | 7,792,424 | |||||
